| | |
| Clinical data | |
|---|---|
| Trade names | Biliscopin, others |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.051.726 |
| Chemical and physical data | |
| Formula | C22H18I6N2O9 |
| Molar mass | 1215.818 g·mol−1 |
| 3D model (JSmol) | |
| |
Iotroxic acid (trade name Biliscopin), used in the form of meglumine iotroxate, is a molecule used as a contrast medium during X-rays. [1] [2] It is specifically used during tests looking at the gallbladder and biliary tract. [2] It is given by slow injection into a vein. [2]
Side effects are uncommon. [3] They include vomiting, skin flushing, headache, itchiness, and low blood pressure. [2] Rare side effects include seizures and allergic reactions. [2] It should not be used by those who have an iodine allergy. [2] Iotroxic acid is an iodine containing contrast media of the diionic dimer type. [4]
Iotroxic acid was first made in 1976. [5] It is on the World Health Organization's List of Essential Medicines. [6] It is rarely used in the developed world due to the availability of magnetic resonance cholangiopancreatography (MRCP). [7]